What’s in Achaogen Incorporated (NASDAQ:AKAO) After Rise in Shorted Shares?

November 14, 2017 - By Darrin Black

 What’s in Achaogen Incorporated (NASDAQ:AKAO) After Rise in Shorted Shares?

Investors sentiment increased to 2.38 in 2017 Q2. Its up 0.60, from 1.78 in 2017Q1. It improved, as 11 investors sold Achaogen Inc shares while 18 reduced holdings. 35 funds opened positions while 34 raised stakes. 32.03 million shares or 27.26% more from 25.17 million shares in 2017Q1 were reported.
State Street accumulated 1.68M shares or 0% of the stock. Blackrock holds 1.87M shares. Airain reported 31,507 shares or 0.03% of all its holdings. University Of Notre Dame Du Lac has invested 0.67% in Achaogen Inc (NASDAQ:AKAO). Tiaa Cref Mngmt Ltd Liability invested in 0% or 78,641 shares. Moreover, Polar Llp has 0.43% invested in Achaogen Inc (NASDAQ:AKAO). Vanguard Grp, a Pennsylvania-based fund reported 1.41M shares. Farallon Limited Liability Corporation holds 0.21% in Achaogen Inc (NASDAQ:AKAO) or 948,500 shares. Hudson Bay Cap Ltd Partnership holds 0.01% of its portfolio in Achaogen Inc (NASDAQ:AKAO) for 21,901 shares. Tower Research Capital Ltd Liability Corporation (Trc) holds 884 shares or 0% of its portfolio. Schwab Charles Inv Management reported 48,300 shares or 0% of all its holdings. Millennium Mngmt Ltd Liability Corporation has 0% invested in Achaogen Inc (NASDAQ:AKAO) for 22,770 shares. The New York-based Alliancebernstein Limited Partnership has invested 0% in Achaogen Inc (NASDAQ:AKAO). Alps Advsrs Inc has invested 0.01% in Achaogen Inc (NASDAQ:AKAO). Rhumbline Advisers has 0% invested in Achaogen Inc (NASDAQ:AKAO) for 32,724 shares.

Since June 12, 2017, it had 0 insider purchases, and 2 sales for $88,962 activity.

The stock of Achaogen Incorporated (NASDAQ:AKAO) registered an increase of 10.63% in short interest. AKAO’s total short interest was 8.82M shares in November as published by FINRA. Its up 10.63% from 7.97 million shares, reported previously. With 911,000 shares average volume, it will take short sellers 10 days to cover their AKAO’s short positions. The short interest to Achaogen Incorporated’s float is 46.18%.

About 185,699 shares traded. Achaogen Inc (NASDAQ:AKAO) has risen 757.99% since November 14, 2016 and is uptrending. It has outperformed by 741.29% the S&P500.

Achaogen, Inc. is a late-stage biopharmaceutical company. The company has market cap of $515.93 million. The Firm is engaged in the discovery, development and commercialization of antibacterial treatments against multi-drug resistant gram-negative infections. It currently has negative earnings. The Firm is involved in researching and developing plazomicin, its lead product candidate, for the treatment of serious bacterial infections, including complicated urinary tract infection (cUTI), blood stream infections and other infections due to MDR Enterobacteriaceae, including carbapenem-resistant Enterobacteriaceae (CRE).

Achaogen Inc (NASDAQ:AKAO) Ratings Coverage

Among 10 analysts covering Achaogen (NASDAQ:AKAO), 9 have Buy rating, 1 Sell and 0 Hold. Therefore 90% are positive. Achaogen had 20 analyst reports since March 16, 2016 according to SRatingsIntel. The rating was initiated by Aegis Capital on Wednesday, November 2 with “Buy”. The rating was maintained by Needham with “Buy” on Friday, September 15. Leerink Swann initiated the shares of AKAO in report on Wednesday, January 4 with “Outperform” rating. The stock of Achaogen Inc (NASDAQ:AKAO) earned “Outperform” rating by Cowen & Co on Monday, November 28. The stock of Achaogen Inc (NASDAQ:AKAO) earned “Outperform” rating by Wedbush on Tuesday, June 14. The stock of Achaogen Inc (NASDAQ:AKAO) earned “Outperform” rating by Wedbush on Wednesday, February 1. The stock has “Buy” rating by Stifel Nicolaus on Thursday, November 9. The stock of Achaogen Inc (NASDAQ:AKAO) has “Outperform” rating given on Monday, October 9 by Leerink Swann. Stifel Nicolaus maintained the stock with “Buy” rating in Thursday, August 3 report. The stock has “Hold” rating by Needham on Wednesday, March 16.

More news for Achaogen Inc (NASDAQ:AKAO) were recently published by: Globenewswire.com, which released: “Achaogen to Present at the Stifel 2017 Healthcare Conference” on November 06, 2017. Seekingalpha.com‘s article titled: “Achaogen’s (AKAO) CEO Kenneth Hillan on Q3 2017 Results – Earnings Call Transcript” and published on November 09, 2017 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.